Sean Ainsworth serves as Executive at Ocuphire Pharma, Inc., where they oversee executive responsibilities. Since joining the company, Sean Ainsworth has executed 8 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 25, 2025 involved receiving (via award) 86,956 shares valued at $100.0K.
Sean Ainsworth currently holds 254,818 shares of Ocuphire Pharma, Inc. (OCUP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Sean Ainsworth has been a net neutral trader of OCUP stock. They have purchased $0 and sold $0 worth of shares.
Sean Ainsworth's most recent insider trade was on Aug 25, 2025, when they sold 86,956 shares at $1.15 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 6, 2023 | OCUP | $0 | Award | 10,976 | $N/A | Discretionary |
| Dec 27, 2022 | OCUP | $0 | Gift | 5,000 | $N/A | Discretionary |
| Oct 19, 2022 | OCUP | $0 | Exercise | 1,574 | $N/A | Discretionary |
| Dec 23, 2021 | OCUP | $0 | Gift | 5,000 | $N/A | Discretionary |
| Nov 19, 2020 | OCUP | $0 | Purchase | 8,865 | $N/A | Discretionary |
| Nov 5, 2020 | OCUP | $0 | Award | 35,800 | $N/A | Discretionary |